Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy

Maria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, Federica Miglietta, Giulia Tasca, Carlo Alberto Giorgi, Enrico Cumerlato, Davide Massa, Marcello Mele, Enrico Orvieto, Valentina Guarneri, PierFranco Conte